Pacific Biosciences Q4 Adj. EPS $(0.12) Beats $(0.15) Estimate, Sales $44.645M Beat $42.530M Estimate

Pacific Biosciences (NASDAQ:PACB) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.15) by 18.37 percent. This is a 40 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $44.645 million which beat the analyst consensus estimate of $42.530 million by 4.97 percent. This is a 13.82 percent increase over sales of $39.224 million the same period last year.